Lpl Financial LLC Immunity Bio, Inc. Transaction History
Lpl Financial LLC
- $238 Billion
- Q4 2024
A detailed history of Lpl Financial LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 257,449 shares of IBRX stock, worth $931,965. This represents 0.0% of its overall portfolio holdings.
Number of Shares
257,449
Previous 153,954
67.22%
Holding current value
$931,965
Previous $571,000
15.41%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IBRX
# of Institutions
228Shares Held
82.2MCall Options Held
1.02MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA17.3MShares$62.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$41.4 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$35.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$14.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.84MShares$13.9 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.45B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...